Drug Type Radiopharmaceuticals and diagnostic agent, Bispecific antibody |
Synonyms- |
Mechanism Histamine succinyl glycine inhibitors(Histamine succinyl glycine inhibitors), MUC1 inhibitors(Mucin-1 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | US | 01 May 2005 | |
Pancreatic Cancer | Preclinical | US | 01 May 2005 |